Objective Gestational diabetes mellitus (GDM) is associated with a higher risk of perinatal morbidity and mortality, and its main complication is the occurrence of large for gestational age (LGA) newborns. The present study aims to characterize pregnant women with GDM and to identify factors associated with the occurrence of LGA newborns in this population. Methods A cross-sectional study was performed based on medical records of women whose prenatal care and delivery were performed at the Maternal and Child Unit of the Hospital Universitário of the Universidade Federal do Maranhão, state of Maranhão, Brazil. A total of 116 pregnant women diagnosed with GDM were included according to the criteria of the International Association of Diabetes and Pregnancy Study Groups (IADPSG). Results The variables associated with LGA newborns after multivariate analysis were: obesity prior to pregnancy (OR ¼ 11.6; 95% CI: 1.40-95.9), previous macrosomia (OR ¼ 34.7; 95% CI: 4.08-295.3), high blood glucose levels in the 3 rd trimester (OR ¼ 2,67; 95% CI: 1.01-7.12) and combined change in the oral glucose tolerance test (OGTT) (fasting þ postdextrose) (OR ¼ 3.53; 95% CI: 1.25-14.2) ¼ 1.17-10.6). Otherwise, insufficient weight gain during pregnancy reduced the risk for LGA newborns (OR ¼ 0.04; 95% CI: 0.01-0.32).
Introduction
Gestational diabetes mellitus (GDM) is classically defined as glucose intolerance resulting in hyperglycemia of variable intensity, with onset or first recognition during pregnancy, which may or may not persist after childbirth.
1
Gestational diabetes mellitus is usually diagnosed through provocative tests using glucose loads. In 2010, the International Association of Diabetes and Pregnancy Study Groups (IADPSG) suggested a new diagnostic criteria based on the 75 g oral glucose tolerance test (75-g OGTT) -performed between 24 and 28 weeks of gestation, with plasma glucose measured at baseline (fasting), after 1 hour, and after 2 hours, wherein one altered measurement (fasting plasma glucose ! 92 mg/dL; 1 hour ! 180 mg/dL; 2 hour ! 153 mg/dL) is sufficient for the diagnosis of GDM. 2 The American Diabetes Association (ADA) endorsed this diagnostic criteria in 2011, and 2 years later, the World Health Organization (WHO) revised and updated this criteria and introduced the recommendations of the IADPSG. 3, 4 Currently, the Brazilian Society of Diabetes and the Brazilian Federation of Gynecology and Obstetrics Associations, similar to the ADA and the WHO, use the same criteria for the diagnosis of GDM.
5
The prevalence of GDM is quite variable, depending on the population under study and on the diagnostic criteria. According to the IADPSG criteria, the prevalence of GDM significantly increased by up to between 15 and 20%.
2 In addition to being related to changes in the diagnostic criteria, this increase is also related to the increasing prevalence of obesity (body mass index [BMI] ! 30 kg/m 2 ), which itself is a risk factor for the onset of GDM. 6 The risk of developing GDM is estimated to be 2, 4, and 8 times greater in overweight, obese, and morbidly obese women, respectively, than in women of healthy weight. 7 Thus, the higher the degree of maternal obesity, the greater the risk of developing GDM, primarily because of insulin resistance.
7,8
Gestational diabetes mellitus is associated with a high risk of perinatal morbidity and mortality, and the main complication is macrosomia or large for gestational age (LGA) fetuses.
9 Macrosomia is defined as birth weight > 4,000 g; however, this definition fails to consider gestational age (GA). Large for gestational age corresponds to birth weight ! 90 th percentile for the corresponding GA.
10
Fetal macrosomia is clinically relevant because it poses risks both for the mother as well as for the fetus. Maternal complications are often related to fetal-pelvic disproportion, prolonged labor, soft-tissue lacerations, high rates of cesarean section, postpartum hemorrhage, and placental retentions arising from uterine atony.
9 It is also associated with perinatal morbidity and mortality; the fetal injuries most commonly associated with macrosomia and shoulder dystocia are fracture of the clavicle and damage to the nerves of the brachial plexus, which can produce Erb paralysis.
11
The literature features substantial variations in factors that increase the probability of macrosomia with respect to the extent of the association between risk factors and excessive birth weight, with the true role of the several factors involved in the genesis of this complication remaining undefined. Fetal macrosomia is related to advanced maternal age, maternal diabetes and glucose intolerance, post-term pregnancy, excessive weight and obesity prior to pregnancy, male fetus, multiparity, excessive weight gain (EWG) during pregnancy, parental height, and an obstetric history of macrosomia.
12,13
The most common and well-described pathogenic mechanism of accelerated fetal growth is related to maternal diabetes mellitus. In maternal hyperglycemia, excess glucose crosses the placenta and reaches the fetal circulation, thereby stimulating fetal insulin secretion. Hyperinsulinemia and excess glucose in utero favors insulin-sensitive tissue hypertrophy, promoting accelerated growth that may lead to macrosomia.
14 recém-nascidos grandes para idade gestacional (GIG To characterize the profile of pregnant women with GDM who are at a higher risk of presenting complications caused by excessive fetal growth, the present study seeks to identify risk factors associated with LGA newborns in this population.
Methods
A cross-sectional study was conducted at the Maternal and Child Unit of the Hospital Universitário of the Universidade Federal do Maranhão, state of Maranhão, Brazil, using information from medical records. The research protocol was approved in advance by the local Research Ethics Committee (opinion number: 1451033).
The present study included pregnant women with GDM diagnosed by OGTT using the IADPSG criteria, whose monitoring and delivery had taken place at the HUMI between January 2015 and December 2017. The exclusion criteria were: pregnant women with plasma glucose ! 126 mg/dl during the 1 st trimester; previous diagnosis of chronic hypertension and collagen diseases; human immunodeficiency virus, hepatitis B or hepatitis C infection; newborns hospitalized in a neonatal intensive care unit (ICU); fetal malformation; and twin pregnancies. The data were collected from maternal and neonatal electronic medical records. The variables studied were the following: maternal age in whole years, categorized as < 35 years old or > 35 years old; maternal height in centimeters; prepregnancy BMI estimated using the Quetelet index and classified according to the Food and Agriculture Organization (FAO)/WHO criteria; gestational weight gain (WG) estimated by the difference between maternal weight at delivery and the usual weight prior to the pregnancy reported at the 1 st prenatal visit. 15, 16 Weight gain was classified according to the Institute of Medicine (IOM) criteria as insufficient (IWG), appropriate (AWG) and EWG.
17
The investigation also included the following: a family history of diabetes among first-degree relatives; obstetric history, including parity, previous pregnancy with macrosomia, and a previous history of GDM; OGTT values upon diagnosis; and blood sugar levels throughout the 3 rd trimester, using the arithmetic mean of capillary blood glucose levels while fasting and 2 hours after breakfast, routinely measured at every visit. The studied characteristics of the newborns were the following: birthweight, gender, type of delivery, and GA. Birthweight was corrected for GA based on the recent recommendations suggested by the Intergrowth study, and it was used to analyze the calculated percentile values with the aid of this tool.
18 Based on calculated percentile values, the newborns were classified as small for gestational age (SGA, weight < 10 th percentile), appropriate for gestational age (AGA, 10 th percentile < weight < 90 th percentile), or
LGA (weight > 90 th percentile). 10 Macrosomia was defined as birth weight ! 4,000 g, regardless of the GA.
10
Data were processed using the software PASW Statistics for Windows, Version 18.0 (SPSS Inc., Chicago, IL, USA). Initially, a descriptive statistical analysis was performed by estimating frequency, mean, and standard deviation (SD). The normality of quantitative variables was tested using the Lilliefors test. Subsequently, analysis of variance (ANOVA) with the post-hoc Tukey test was used for the comparative analysis of numerical variables. The distribution of categorical variables was analyzed using the chi-squared test or the Fisher exact test. Odds ratio (OR) and 95% confidence intervals (CIs) were used to assess the association with the LGA outcome. A multivariate logistic regression model was built to estimate the ORs adjusted for variables presenting a p-value < 0.10 in the bivariate analysis. Variables related to glycemia parameters were not adjusted to avoid multicollinearity. In addition, receiver operating characteristic (ROC) curves were analyzed to estimate the area under the curve (AUC), and a 95% CI was established to predict LGA newborns using OGTT levels (at 0, 60, and 120 minutes). The significance level adopted for all of the analyses was of 5%.
Results
In total, 116 pregnant women with GDM were included in the present study. The mean age was 32.7 AE 6.4 (range: 18-44) years old; 41.1% of the women had a family history of diabetes among their first-degree relatives, and 25% were multiparous. The mean GA at delivery was 38.1 AE 1.5 weeks, with a cesarean section rate of 75%. The overall occurrence of LGA newborns was of 25.9%.
With regard to prepregnancy BMI, 28% (32/116), 31% (35/ 116), and 43% (49/116) of the women had normal weight, were overweight, and were obese, respectively. Considering the IOM recommendations for WG during pregnancy, $ 35% of the pregnant women had EWG, with a similar percentage being observed for WG in each prepregnancy BMI category (►Table 1). Large for gestational age newborns were more frequent in overweight and obese women. Macrosomia was only more frequent in the group of mothers who were obese before pregnancy (►Table 2). Only four women had SGA newborns and, of these, only one had insufficient WG during pregnancy.
The mean GA when OGTT was conducted was 25 weeks. At the time of the test, $ 13% of the diagnoses were because of changes only in fasting plasma glucose, and 50.9% were because of changes in both fasting and post-dextrose load. The mean fasting plasma glucose level at the time of the test was higher in the group of pregnant women who were overweight and obese prior to the pregnancy (►Table 1).
With regard to treatment, $ 43% of the pregnant women received only insulin as a medical therapy during pregnancy. Blood glucose levels were monitored during the 3 rd trimester, and the mean fasting blood glucose level was higher in the group of women who were obese prior to the pregnancy (►Table 1).
The percentage of LGA newborns was statistically higher among women with overweight, with obesity, with a previous history of macrosomia, with high mean fasting blood glucose in the 3 rd trimester, with changes in 3 OGTT measurements, and with a combined change in the OGTT (fasting þ after dextrose load). In women with IWG during pregnancy, the percentage of LGA newborns was statistically lower. After the multivariate analysis, the following factors were associated with LGA newborns: obesity (OR ¼ 11.6; 95% CI: 1.40-95.9), previous macrosomia (OR ¼ 34.7; 95% CI: 4.08-295.3), high The prediction of the occurrence of LGA newborns was estimated using plasma glucose values from the OGTT at 0, 60, and 120 minutes (►Fig. 1). The data show an area under the curve (AUC) of 0.647 (0.552-0.735) at 0 minutes, of 0.525 (0.413-0.634) at 60 minutes, and of 0.661 (0.567-0.747) at 120 minutes, thus demonstrating that at 0 and 120 minutes were the times that best predicted the occurrence of LGA newborns (p < 0.05).
Discussion
In the present study, the incidence of LGA newborns was of 25.9%; in the literature, this incidence varies from 15 to 45%.
19,20
Several studies have shown the influence of prepregnancy BMI, as well as of weight gain during pregnancy, on fetal weight. 21, 22 Obesity is currently one of the major public Abbreviations: BMI, body mass index; CI, confidence interval;
LGA, large for gestational age; OGTT, oral glucose tolerance test; OR, odds ratio. Ã Statistically significant differences in the prevalence of LGA (p < 0.05). Adjustment of the OR for pregestational BMI variables, previous macrosomia, weight gain categories, mean fasting blood glucose during the 3 rd trimester, number of altered points and categories of OGTT. health problems, and its prevalence has been increasing among women of reproductive age. Obesity during pregnancy is associated with an increased risk of gestational hypertension, preeclampsia, fetal macrosomia, and with the need for cesarean section, in addition to the risk of developing GDM. 23 Among Brazilian pregnant women, a BMI > 25 kg/ m 2 was related to an increased risk of fetal macrosomia and GDM.
13
Excessive birthweight is more frequent among obese mothers, regardless of the association with diabetes.
24 Maternal obesity is associated with reduced sensitivity to insulin and consequential hyperinsulinemia, which, incremented by high levels of triglycerides, favor excessive fetal growth, regardless of plasma glucose levels. 8 Some authors state that maternal obesity is the leading factor for the occurrence of LGA newborns. Black et al 23 reported a 21.6% frequency of
LGA newborns among overweight or obese pregnant women without GDM, a percentage that rose to 23.3% when the factors obesity and GDM were combined, whereas the frequency of LGA newborns among women with normal weight and GDM was only 2.9%. It is estimated that between 65 and 75% of the women with GDM are also overweight or obese. 23 In our sample, 72.4% of the women with GDM were overweight or obese before the pregnancy, and the percentage of LGA newborns was higher among these women, with obesity being an independent risk factor for LGA newborns after the adjusted analysis. The risk for
LGA newborns also appears to increase when WG is considered regardless of prior BMI. 19 Miao et al 25 found a higher incidence of macrosomia among pregnant women with EWG, as did Alberico et al, 26 who observed that EWG during pregnancy was significantly associated with macrosomia, with a 2.6-fold higher risk in comparison with the recommended WG. 25, 26 Mastella et al 27 found that EWG during pregnancy was an independent risk factor for LGA newborns, and that WG during the 3 rd trimester was also associated with LGA newborns. In the present study, EWG was not a risk factor for the birth of LGA newborns. The limited sample and possible errors in the self-reported prepregnancy weight may have altered the amount of gained weight. Although the IOM guidelines for gestational WG are not specific for pregnant women with GDM, they are often applied to them. It is unknown whether the IOM recommendations are appropriate for pregnant women at increased risk of adverse outcomes, or if adjusting these guidelines for women with GDM could improve perinatal outcomes. 28 It can be assumed that women with GDM require more stringent WG recommendations because of the association of EWG and hyperglycemia and their potentially additive effects that lead to adverse outcomes, such as LGA newborns.
28
Miao et al 25 found that IWG decreased the risk for LGA newborns. This study also showed that WG below that recommended by the IOM was a protective factor for the outcome of LGA newborns, but it is necessary to consider the small sample and the limited statistical power of this analysis. also showed that a history of fetal macrosomia is a significant risk factor for the recurrence of macrosomia in subsequent pregnancies. Although a history of macrosomia is a nonmodifiable factor, it serves as a marker of major metabolic changes during pregnancy and, in these cases, health care providers should pay attention to potentially influential factors for excessive fetal growth that can be controlled. With regard to blood glucose levels in the 3 rd trimester, high fasting glucose level was an independent risk factor for LGA newborns. Legardeur et al 34 observed that fasting blood glucose ! 95 mg/dL doubled the risk for fetal macrosomia. Thus, adequate glycemic control throughout the pregnancy, through diet and/or insulin therapy, especially in the 3 rd trimester, should be intense to reduce risks. The occurrence of LGA newborns was significantly higher in the group of women with combined change in the OGTT (fasting þ after the dextrose load), even after the multivariate analysis. Brankica et al 35 found that the combination of fasting blood glucose and blood glucose 1 hour after the glucose load in the OGTT was a predictor of occurrence of LGA newborns. Pregnant women exhibiting this combination may be considered at increased risk because of the fact that they have two distinct changes, altered fasting glucose and glucose intolerance, which suggests impairment in two different metabolic pathways associated with the disease, dysfunction of pancreatic β cells and insulin resistance.
36
In the present study, the ROC curve analysis showed that plasma glucose 2 hours after the glucose load in the OGTT was a better predictor for LGA newborns. Silva et al have also identified high levels of plasma glucose at the 2-hour measurement in the OGTT as one of the major independent risk factors for LGA newborns. 19 Brankica et al 35 and Ouzilleau et al 37 found high levels of fasting blood glucose to be better predictors, whereas Mello et al 38 showed that 1-hour blood glucose was the factor most closely associated with LGA newborns.
35,37,38

Conclusion
The present study with pregnant women diagnosed with GDM showed that maternal prepregnancy obesity, history of macrosomia, combined change in the OGTT (fasting þ after dextrose load), and high-fasting glycemic mean during the 3 rd trimester were independent predictive factors for LGA newborns. Weight gain below that recommended by the IOM seems to be a protective factor for the occurrence of LGA newborns, and the need for specific recommendations for pregnant women with GDM may be suggested. However, more studies, with larger numbers of participants, are necessary to validate this finding. Maternal pregestational obesity and high-fasting glycemic mean in the 3 rd trimester are modifiable factors, so preventive measures or therapeutic intervention can be implemented to minimize these risk factors. In general, retrospective studies present limitations related to the data obtained. Nonetheless, the present study highlights factors associated with LGA newborns of pregnant women with GDM in Brazil, which may be useful in the management of these patients during pregnancy and in preventing complications for the mothers and for the fetuses.
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